Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Europe’s “Nuclear Option” Against Trump Tariffs: Selling US Assets Is Talked About—But Hard to Execute

by Team Lumida
January 20, 2026
in Macro
Reading Time: 3 mins read
A A
0
Trump Suggests $2,000 Tariff-Funded Payouts to Americans
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key takeaways

Powered by lumidawealth.com

  • European investors hold a massive pool of US assets (over $10T in the EU alone), raising speculation that selling could be used as leverage in the Greenland-linked tariff dispute.
  • In practice, governments have limited control: most holdings sit in private pensions and funds, and forced selling would likely damage European savers as much as US markets.
  • Even discussing “weaponization of capital” signals rising tail risk—turning a trade fight into a potential capital-markets conflict.
  • Markets are already showing a mild “Sell America” reaction (pressure on US assets, support for havens), but strategists see asset dumping as unlikely without further escalation.

What Happened?

As tensions flare over President Trump’s renewed tariff threats tied to Greenland, investors are debating whether Europe could retaliate by selling US bonds and equities. The argument is straightforward: the US relies on foreign capital, so large-scale selling could push US yields higher and weigh on equities. Strategists note, however, that most European-held US assets are owned by private-sector investors rather than governments, limiting policymakers’ ability to act directly.

Why It Matters?

This introduces a new, more consequential risk channel for markets. Trade wars typically hit growth expectations and corporate margins; a “financial war” would directly pressure funding conditions, risk premia, and asset prices through capital flows. Even if the probability is low, the impact could be large: higher Treasury yields would tighten financial conditions, a weaker dollar could follow, and equity multiples could compress—especially if the market starts to question the durability of “US exceptionalism.” For Europe, the constraint is self-inflicted damage: selling US assets at scale would likely hurt European pensions and portfolios and could trigger broader volatility.

What’s Next?

Watch for signs that official Europe is moving from trade countermeasures toward capital-market signaling—such as public-sector funds slowing US purchases, policy rhetoric encouraging “rebalancing” toward euro assets, or incentives favoring domestic capital allocation. The more immediate focus is the escalation path: if tariff threats broaden and retaliation intensifies, the tail risk of capital weaponization rises. For markets, the key indicators are cross-asset stress signals—moves in Treasury yields, the dollar, credit spreads, and haven demand—showing whether “Sell America” remains a short-lived trade or becomes a persistent allocation shift.

Source
Previous Post

a16z Doubles Down on AI Infrastructure With a $3B War Chest—Betting Demand Outruns Bubble Fears

Next Post

The $4.6 Trillion Inheritance Wave Is Rewiring Luxury Real Estate

Recommended For You

U.S.–China Trade Talks Resume Ahead of Trump–Xi Summit

by Team Lumida
31 minutes ago
U.S. Struggles to Break China’s Grip on Critical Minerals as Syrah Resources Faces Setbacks

Key takeaways Powered by lumidawealth.com U.S. and Chinese trade chiefs plan a mid-March meeting to prepare for a Trump–Xi summit. Potential agenda items include Boeing purchases, U.S. soybean commitments,...

Read more

US–Iran War Escalates After Khamenei Killed, Oil Surges and Markets Turn Risk-Off

by Team Lumida
1 day ago
aerial view of city buildings during daytime

Key takeaways Powered by lumidawealth.com The U.S. and Israel launched large-scale strikes on Iran, killing Supreme Leader Ayatollah Ali Khamenei and hitting military, missile, and IRGC targets. Trump signaled...

Read more

U.S.–Israel Strike on Iran Sends Oil Higher as Markets Price Risk of Wider Middle East War

by Team Lumida
3 days ago
House Rebuke of Canada Tariffs Exposes Political Risk Around Trump’s Trade Agenda

Key takeaways Powered by lumidawealth.com U.S. and Israel launched coordinated strikes on Iran’s military and leadership targets, escalating regional conflict risk. Iran retaliated with missile and drone attacks across...

Read more

Fed Moves to Quash DOJ Subpoenas in Powell Probe, Escalating Independence Standoff

by Team Lumida
4 days ago
September Rate Cut Likely as Job Market Risks Increase, Says Fed

Key takeaways Powered by lumidawealth.com The Federal Reserve is seeking to quash DOJ subpoenas issued in a criminal probe into Jerome Powell’s congressional testimony on building renovations. The investigation,...

Read more

U.S. Raises the Stakes in Iran Nuclear Talks With “Zero-Enrichment” Demands as Strike Risk Looms

by Team Lumida
5 days ago
U.S. Raises the Stakes in Iran Nuclear Talks With “Zero-Enrichment” Demands as Strike Risk Looms

Key takeaways Powered by lumidawealth.com The U.S. is pressing Iran to dismantle major nuclear sites and hand over enriched uranium, aiming for a permanent deal with no sunset clauses....

Read more

$112B Cargo Gap Signals Record Tariff Evasion Pressure

by Team Lumida
6 days ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

Key takeaways Powered by lumidawealth.com Trade data shows a $112 billion gap between what China reports exporting to the US and what US Customs records as arriving. The discrepancy...

Read more

Trump’s 10% Global Tariff Takes Effect as White House Rebuilds Trade Strategy

by Team Lumida
1 week ago
White House, Washington DC

Key takeaways Powered by lumidawealth.com A 10% global baseline tariff is now in force under Section 122 of the 1974 Trade Act. The White House is preparing an order...

Read more

China Sees Leverage After Court Weakens Trump’s Tariff Hand Ahead of Beijing Summit

by Team Lumida
1 week ago
China Sees Leverage After Court Weakens Trump’s Tariff Hand Ahead of Beijing Summit

Key takeaways Powered by lumidawealth.com The Supreme Court’s decision lowered the effective U.S. tariff rate on Chinese goods from ~32% to ~23%, narrowing China’s relative disadvantage. Beijing sees an...

Read more

$133 Billion in Tariffs Now in Legal Limbo After Supreme Court Ruling

by Team Lumida
1 week ago
$133 Billion in Tariffs Now in Legal Limbo After Supreme Court Ruling

Key takeaways Powered by lumidawealth.com The Supreme Court invalidated tariffs imposed under IEEPA, placing $133.5B in collected duties in potential legal jeopardy. IEEPA tariffs accounted for 67% of 2025...

Read more

Tariffs Aren’t Fixing the Trade Deficit: Export Powers Double Down as U.S. Imports Hit Record

by Team Lumida
1 week ago
Tariffs Aren’t Fixing the Trade Deficit: Export Powers Double Down as U.S. Imports Hit Record

Key takeaways Powered by lumidawealth.com The U.S. goods trade deficit hit a record $1.24T in 2025, driven by rising imports, despite Trump’s tariff push. Major exporters (Germany, Japan, South...

Read more
Next Post
Climate-Risk Scores Are Now a Hidden “Third Price” in Housing — and Sellers Are Fighting Back

The $4.6 Trillion Inheritance Wave Is Rewiring Luxury Real Estate

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Credit Fuels AI Boom Amid Bubble Concerns as Investors Pour Billions into Infrastructure

August 24, 2025
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

China Signals Openness to U.S. Trade Talks, Demands Tariff Removal as a Show of Sincerity

May 2, 2025
Dell Shares Soar: AI Server Demand Fuels Record-Breaking Quarter!”

Dell Shares Soar: AI Server Demand Fuels Record-Breaking Quarter!”

August 30, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018